Suh KS - Search Results

1

Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.

Song S, Kim K, Chie EK, Kim S, Park HJ, Yi NJ, Suh KS, Ha SW. Song S, et al. Among authors: suh ks. Clin Transl Oncol. 2015 Oct;17(10):825-9. doi: 10.1007/s12094-015-1312-0. Epub 2015 Jun 4. Clin Transl Oncol. 2015. PMID: 26041722

2

Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.

Kim H, Ahn SW, Hong SK, Yoon KC, Kim HS, Choi YR, Lee HW, Yi NJ, Lee KW, Suh KS; Korean Liver Cancer Association. Kim H, et al. Among authors: suh ks. Br J Surg. 2017 Jul;104(8):1045-1052. doi: 10.1002/bjs.10541. Epub 2017 May 8. Br J Surg. 2017. PMID: 28480964

3

Primary Living-donor Liver Transplantation Is Not the Optimal Treatment Choice in Patients With Early Hepatocellular Carcinoma With Poor Tumor Biology.

Park MS, Lee KW, Kim H, Choi YR, Hong G, Yi NJ, Suh KS. Park MS, et al. Among authors: suh ks. Transplant Proc. 2017 Jun;49(5):1103-1108. doi: 10.1016/j.transproceed.2017.03.016. Transplant Proc. 2017. PMID: 28583536

4

Outcome and technical aspects of liver retransplantation: analysis of 25-year experience in a single major center.

Kim H, Lee KW, Yi NJ, Lee HW, Choi Y, Suh SW, Jeong J, Suh KS. Kim H, et al. Among authors: suh sw, suh ks. Transplant Proc. 2015 Apr;47(3):727-9. doi: 10.1016/j.transproceed.2014.12.037. Transplant Proc. 2015. PMID: 25891719

5

Usefulness of PIVKA-II After Living-donor Liver Transplantation for Hepatocellular Carcinoma.

Park MS, Lee KW, Kim H, Choi YR, Hong G, Yi NJ, Suh KS. Park MS, et al. Among authors: suh ks. Transplant Proc. 2017 Jun;49(5):1109-1113. doi: 10.1016/j.transproceed.2017.03.017. Transplant Proc. 2017. PMID: 28583537

6

De Novo Hepatitis B Virus Infection After Liver Transplantation in Hepatitis B Core-positive Recipients Using Hepatitis B Core-negative Grafts.

Nugroho A, Lee KW, Kim H, Yi NJ, Suh KS. Nugroho A, et al. Among authors: suh ks. Transplant Proc. 2019 Apr;51(3):842-844. doi: 10.1016/j.transproceed.2018.10.025. Epub 2019 Jan 7. Transplant Proc. 2019. PMID: 30979473

7

High viremia, prolonged Lamivudine therapy and recurrent hepatocellular carcinoma predict posttransplant hepatitis B recurrence.

Chun J, Kim W, Kim BG, Lee KL, Suh KS, Yi NJ, Park KU, Kim YJ, Yoon JH, Lee HS. Chun J, et al. Among authors: suh ks. Am J Transplant. 2010 Jul;10(7):1649-59. doi: 10.1111/j.1600-6143.2010.03162.x. Am J Transplant. 2010. PMID: 20642687 Free article.

8

The effect of pretransplantation lamivudine resistance on the prognosis of liver transplant recipients.

Jung YJ, Kim BG, Kim JS, Kim W, Yoon JH, Lee HS, Yi NJ, Lee KW, Suh KS, Kim YJ. Jung YJ, et al. Among authors: suh ks. Transplant Proc. 2013 Jan-Feb;45(1):231-5. doi: 10.1016/j.transproceed.2012.06.078. Transplant Proc. 2013. PMID: 23375306

9

Inexplicable Outcome of Early Appearance of Hepatocellular Carcinoma in the Allograft After Deceased Donor Liver Transplantation: A Case Report.

Navarro Burgos JB, Lee KW, Shin YC, Lee DS, Lee KB, Yi NJ, Suh KS. Navarro Burgos JB, et al. Among authors: suh ks. Transplant Proc. 2015 Dec;47(10):3012-5. doi: 10.1016/j.transproceed.2015.10.040. Transplant Proc. 2015. PMID: 26707329 Review.

10

Urinary Neutrophil Gelatinase-Associated Lipocalin as a Biomarker for Renal Injury in Liver Transplant Recipients Using Calcineurin Inhibitors.

Yoon KC, Lee KW, Oh SC, Kim H, Kim HS, Hong SK, Ahn SW, Yi NJ, Suh KS. Yoon KC, et al. Among authors: suh ks. Transplant Proc. 2018 Dec;50(10):3667-3672. doi: 10.1016/j.transproceed.2018.09.009. Epub 2018 Sep 8. Transplant Proc. 2018. PMID: 30577253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

755 results

Search Page

Filters